Waldenstrom Macroglobulinemia (WM) is a rare type of non-Hodgkin lymphoma characterized by the overproduction of abnormal white blood cells called lymphoplasmacytic cells. While it is considered a rare disease, the exact prevalence of WM is not well-established due to its rarity and the lack of comprehensive population-based studies.
However, it is estimated that WM accounts for approximately 1-2% of all hematologic malignancies. The incidence of WM varies across different regions and populations, with slightly higher rates reported in Western countries. It predominantly affects older individuals, with the median age at diagnosis being around 70 years.
WM is slightly more common in men than in women, and there is a higher incidence among Caucasians compared to other ethnic groups. It is important to note that these statistics are general estimates and may vary based on specific populations and geographical locations.
Early diagnosis and appropriate management are crucial for improving outcomes in WM patients. If you suspect any symptoms or have concerns about Waldenstrom Macroglobulinemia, it is essential to consult a healthcare professional for proper evaluation and guidance.